Skip to main content
Neural Therapeutics Inc. logo

Neural Therapeutics Inc. — Investor Relations & Filings

Ticker · NURL ISIN · CA64134N2032 LEI · 894500KBZO3KS9715774 CSE Manufacturing
Open in API
Filings indexed 141 across all filing types
Latest filing 2025-03-31 Interim / Quarterly Rep…
Country CA Canada
Listing CSE NURL

About Neural Therapeutics Inc.

https://neuraltherapeutics.ca/

Neural Therapeutics Inc. is an ethnobotanical drug discovery and development company operating in the pharmaceutical and nutraceutical sectors. It focuses on developing therapeutic drugs for mental illnesses, including those related to substance abuse, and over-the-counter dietary supplements. The company integrates modern scientific research with traditional indigenous knowledge regarding psychoactive plants and whole plant extracts. Initial R&D centers on the San Pedro cactus (Echinopsis pachanoi), which contains mescaline. Neural Therapeutics pursues a dual-path strategy to develop both pharmaceutical and nutraceutical products, aiming for whole plant utilization and zero waste.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited Interim Condensed Financial Statements' for the three and six months ended January 31, 2025. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Cashflows, and Statement of Changes in Shareholders' Deficit) along with detailed explanatory notes. This meets the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2025
2025-03-31 English
News release - English.pdf
Regulatory Filings
2025-03-31 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 85% confidence The document is a Canadian regulatory compliance form (Form 45-106F1) reporting an exempt distribution under National Instrument 45-106. It is not an investor presentation, earnings release, or management report, nor is it an AGM or annual report. It is a mandatory regulatory filing providing details of security distributions. The best fitting category is the general fallback for miscellaneous regulatory filings (Code: RNS).
2025-03-18 English
News release - English.pdf
Regulatory Filings Classification · 80% confidence The document is a corporate press release announcing commencement of trading on the Canadian Securities Exchange, providing business updates including the closing of Series A financing and strategic LOI, and the engagement of investor relations consultants. It is not an earnings release, financial report, M&A completion notice, dividend notice, or any other specific report category. Therefore, it falls into the general “Regulatory Filings” fallback category for miscellaneous corporate announcements (RNS).
2025-03-17 English
Material change report - English.pdf
Regulatory Filings Classification · 92% confidence The document is a Canadian securities regulatory filing titled “FORM 51-102F3 Material Change Report,” with numbered items detailing the material change, reliance on National Instrument 51-102, and filing on SEDAR+. It is not an earnings release, proxy, or annual/interim report but a required statutory material change report under NI 51-102. It therefore falls under the catch-all “Regulatory Filings” category (RNS).
2025-03-13 English
News release - English.pdf
Capital/Financing Update Classification · 92% confidence The document is a corporate press release announcing the closing of a Series A private placement, issuance of warrants, listing approval on the Canadian Securities Exchange, and related share transactions. These are direct updates on the company’s fundraising and capital structure changes. There are no quarterly or annual financial results, no management discussion of results, nor call transcript elements. Hence, it falls under “Capital/Financing Update” (CAP).
2025-03-13 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.